Upgrade to SI Premium - Free Trial

bluebird bio (BLUE) PT Raised to $85 at Leerink Partners

December 1, 2016 11:26 AM
Leerink Partners analyst Michael Schmidt reiterated an Outperform rating and lowered his price target on bluebird bio (NASDAQ: BLUE) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles